Having trouble accessing articles? Reset your cache.

H1N1 influenza vaccine: Phase I started

Not-for-profit Fraunhofer USA Center for Molecular Biotechnology (Newark, Del.) began a single-blind, placebo-controlled, dose-escalation, U.S. Phase I trial

Read the full 183 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE